Cost-effectiveness of an in-development adult-formulated pneumococcal vaccine in older US adults
Angela R. Wateska, Mary Patricia Nowalk, Chyongchiou J. Lin, Lee H. Harrison, William Schaffner, Richard K. Zimmerman, Kenneth J. Smith
Topics & Concepts
MedicineVaccinationPneumococcal conjugate vaccineCohortPopulationCost effectivenessEpidemiologyDisease burdenPneumococcal infectionsVaccine efficacyQuality-adjusted life yearCohort studyPediatricsImmunologyEnvironmental healthStreptococcus pneumoniaeInternal medicineBacteriaGeneticsRisk analysis (engineering)BiologyPneumonia and Respiratory InfectionsRespiratory viral infections researchInfluenza Virus Research Studies